MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $58,000 | -52.1% | 18,769 | -36.6% | 0.00% | – |
Q4 2016 | $121,000 | -30.1% | 29,616 | +8.6% | 0.00% | – |
Q3 2016 | $173,000 | +31.1% | 27,263 | +11.3% | 0.00% | – |
Q2 2016 | $132,000 | -30.9% | 24,488 | +7.5% | 0.00% | – |
Q1 2016 | $191,000 | +61.9% | 22,776 | +52.6% | 0.00% | – |
Q4 2015 | $118,000 | -65.5% | 14,929 | -62.9% | 0.00% | -100.0% |
Q3 2015 | $342,000 | -29.9% | 40,221 | +2.0% | 0.00% | 0.0% |
Q2 2015 | $488,000 | +17.6% | 39,439 | +13.0% | 0.00% | 0.0% |
Q1 2015 | $415,000 | -0.2% | 34,899 | -5.1% | 0.00% | 0.0% |
Q4 2014 | $416,000 | +135.0% | 36,791 | +82.0% | 0.00% | – |
Q3 2014 | $177,000 | +142.5% | 20,210 | +39.8% | 0.00% | – |
Q1 2014 | $73,000 | -16.1% | 14,453 | -11.5% | 0.00% | – |
Q4 2013 | $87,000 | +102.3% | 16,330 | +42.7% | 0.00% | – |
Q3 2013 | $43,000 | – | 11,443 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |